在同情使用计划的设置中,对mepolizumab的hypereosinophilic综合征反应
Gauthier Coussement1, Julien Catherine1,2, Florence Roufosse1,2
1Department of Internal Medicine, Hôpital Erasme, Université Libre de Bruxelles, 808 Route de Lennik, 1070 Brussels, Belgium.
Journal of leukocyte biology
|July 6, 2024
概括
梅波利祖马布有效治疗过敏氨酸性综合征 (HES),在受影响器官较少或单器官 HES 的患者中观察到完整的反应. 淋巴细胞变异HES (L-HES) 的反应较小,表明需要个性化治疗方法.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 梅波利祖马布 (Mepolizumab) 是一种抗氨基-5抗体,是治疗高氨酸性综合征 (HES) 的批准疗法.
- 在HES中最佳的患者选择和梅波利祖马布的剂量仍在调查中.
研究的目的:
- 为了确定患者和疾病特征,与HES.mepolizumab的良好反应相关.
- 为了评估mepolizumab的剂量要求和治疗结果在一个富有同情心的使用计划.
主要方法:
- 在一个同情使用计划中对18名HES患者进行了回顾性观察性研究.
- 对患者人口统计,疾病特征,梅波利祖马布剂量和临床/血液学反应的分析.
主要成果:
- 对梅波利祖马布的完整反应与受影响器官的减少,较低的葡萄糖皮质体 (GC) 使用 (≤10毫克普雷尼松等效) 和单器官HES相关.
- 淋巴细胞变异HES (L-HES) 显示反应率较差,梅波利祖马布剂量要求更高.
- 患有单个器官HES的患者,特别是肺部参与者,表现出很好的反应,允许剂量间隔增加.
结论:
- 梅波利祖马布在HES中是有效和安全的,特定的患者亚组显示出优异的结果.
- 单器官HES患者可能是"超级响应者",可能受益于优化剂量策略.
- 由于对梅波利祖马布的反应有限,L-HES患者可能需要替代或调整治疗方法.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
267
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
267
01:20Asthma: Pathogenesis and Management
381
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
381
02:06Allergic Reactions
27.3K
Overview
27.3K
01:17Drugs Used in Lower Respiratory Disorders: Overview
397
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
397